Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Higher androgen levels do not cause baldness in men.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Exercise and finasteride together improve ovary health in PCOS rats.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Hair can reliably measure average estradiol levels over months in humans and monkeys.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

A woman developed male characteristics after using unregulated hormone therapy.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.